stock price

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

XORTX Shareholders Back 5-to-1 Consolidation to Avert NASDAQ Delisting

XORTX shareholders approved a 5-to-1 share consolidation to maintain NASDAQ compliance, reducing shares from 6.96M to 1.39M ahead of April 2026 deadline.
XRTXkidney diseaseshare consolidation
The Motley FoolThe Motley Fool··Robert Izquierdo

Kulicke and Soffa Director Sells $1.4M in Stock as Shares Near 52-Week Peak

Kulicke and Soffa director sold $1.4M in stock near 52-week peak, reducing holdings by 19.6%. Sale occurs as company benefits from AI-driven semiconductor demand.
KLICvaluation concernssemiconductor equipment
BenzingaBenzinga··Erica Kollmann

Nano Nuclear Energy Stock Gains on Better-Than-Expected Q1 Loss

Nano Nuclear Energy stock rose 1.03% after reporting Q1 loss of 13 cents per share, beating expectations of 29 cents and signaling improved operational efficiency.
NNEnuclear energyearnings report
The Motley FoolThe Motley Fool··Adria Cimino

Nvidia's Valuation Reaches Year-Low as AI Investment Uncertainty Weighs

Nvidia's stock hits year-low valuations amid AI investment uncertainty and OpenAI partnership delays, though analysts expect recovery as AI infrastructure demand remains strong long-term.
NVDAAI chipsvaluation
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Trinity Biotech Faces Nasdaq Delisting Risk Over Minimum Price Compliance

Trinity Biotech received a Nasdaq delisting warning after failing to maintain the $1.00 minimum bid price. The company has until August 2026 to restore compliance or face delisting.
TRIBbiotechnologystock price